Stock analysts at Aegis started coverage on shares of Happiness Biotech Group (NASDAQ:HAPP) in a research report issued on Friday, The Fly reports. The firm set a “buy” rating on the stock.
HAPP traded up $0.07 on Friday, reaching $4.88. The company had a trading volume of 206 shares, compared to its average volume of 35,554. Happiness Biotech Group has a 52-week low of $3.91 and a 52-week high of $5.24.
About Happiness Biotech Group
Recommended Story: How Investors Use a Balance Sheet
Receive News & Ratings for Happiness Biotech Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Happiness Biotech Group and related companies with MarketBeat.com's FREE daily email newsletter.